Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001447348-12-000003)

Filing Details

Accession Number:: 0001447348-12-000003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-01-12 13:16:31
Reporting Period:: 2011-10-26

Filing Date:: 2012-01-12
Accepted Time:: 2012-01-12 13:16:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
835887	Progenics Pharmaceuticals Inc	PGNX	Pharmaceutical Preparations (2834)	133379479

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1331438	Robert Mark Baker	777 Old Saw Mill River Road Tarrytown NY 10591	Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-10-26	1	$6.53	37,680	No	4	P	Direct
Common Stock	Acquisiton	2011-10-26	455	$6.52	38,135	No	4	P	Direct
Common Stock	Acquisiton	2011-10-26	76	$6.50	38,211	No	4	P	Direct
Common Stock	Acquisiton	2012-01-11	191	$8.86	39,036	No	4	P	Direct
Common Stock	Acquisiton	2012-01-11	200	$8.87	39,236	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.